{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:47:41Z","timestamp":1740138461081,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s12033-024-01057-1","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T09:03:27Z","timestamp":1707815007000},"page":"342-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression of VEGFR2 Ligand Binding Domain in Pichia pink\u2122 4 Cells and Evaluation of Its Interactions with VEGF-A165 Receptor Binding Domain"],"prefix":"10.1007","volume":"67","author":[{"given":"Zahra","family":"Fathi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud Mashhadi Akbar","family":"Boojar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza H.","family":"Sajedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Dehnavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-3465","authenticated-orcid":false,"given":"Zohreh","family":"Jahanafrooz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,13]]},"reference":[{"issue":"5","key":"1057_CR1","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0969-2126(98)00065-3","volume":"6","author":"WJ Fairbrother","year":"1998","unstructured":"Fairbrother, W. J., Champe, M. A., Christinger, H. W., Keyt, B. A., & Starovasnik, M. A. (1998). Solution structure of the heparin-binding domain of vascular endothelial growth factor. Structure, 6(5), 637\u2013648.","journal-title":"Structure"},{"issue":"10","key":"1057_CR2","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/S0969-2126(97)00284-0","volume":"5","author":"YA Muller","year":"1997","unstructured":"Muller, Y. A., Christinger, H. W., Keyt, B. A., & de Vos, A. M. (1997). The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 \u00c5 resolution: multiple copy flexibility and receptor binding. Structure, 5(10), 1325\u20131338.","journal-title":"Structure"},{"issue":"14","key":"1057_CR3","doi-asserted-by":"publisher","first-page":"7192","DOI":"10.1073\/pnas.94.14.7192","volume":"94","author":"YA Muller","year":"1997","unstructured":"Muller, Y. A., Li, B., Christinger, H. W., Wells, J. A., Cunningham, B. C., & De Vos, A. M. (1997). Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site. Proceedings of the National Academy of Sciences, 94(14), 7192\u20137197.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"1057_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jmgm.2018.04.015","volume":"82","author":"U Uciechowska-Kaczmarzyk","year":"2018","unstructured":"Uciechowska-Kaczmarzyk, U., Babik, S., Zsila, F., Bojarski, K. K., Beke-Somfai, T., & Samsonov, S. A. (2018). Molecular dynamics-based model of VEGF-A and its heparin interactions. Journal of Molecular Graphics and Modelling, 82, 157\u2013166.","journal-title":"Journal of Molecular Graphics and Modelling"},{"issue":"4","key":"1057_CR5","first-page":"621","volume":"65","author":"M Zajkowska","year":"2018","unstructured":"Zajkowska, M., Lubowicka, E., Malinowski, P., Szmitkowski, M., & \u0141awicki, S. (2018). Plasma levels of VEGF-A, VEGF B, and VEGFR-1 and applicability of these parameters as tumor markers in diagnosis of breast cancer. Acta Biochimica Polonica, 65(4), 621\u2013628.","journal-title":"Acta Biochimica Polonica"},{"issue":"7","key":"1057_CR6","first-page":"1781","volume":"119","author":"MS Brozzo","year":"2012","unstructured":"Brozzo, M. S., Bjeli\u0107, S., Kisko, K., Schleier, T., Lepp\u00e4nen, V.-M., Alitalo, K., et al. (2012). Thermodynamic and structural description of allosterically regulated VEGFR-2 dimerization. Blood, The Journal of the American Society of Hematology, 119(7), 1781\u20131788.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"6","key":"1057_CR7","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1073\/pnas.0914318107","volume":"107","author":"V-M Lepp\u00e4nen","year":"2010","unstructured":"Lepp\u00e4nen, V.-M., Prota, A. E., Jeltsch, M., Anisimov, A., Kalkkinen, N., Strandin, T., et al. (2010). Structural determinants of growth factor binding and specificity by VEGF receptor 2. Proceedings of the National Academy of Sciences, 107(6), 2425\u20132430.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"1057_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pep.2013.04.010","volume":"90","author":"W Cao","year":"2013","unstructured":"Cao, W., Li, H., Zhang, J., Li, D., Acheampong, D. O., Chen, Z., et al. (2013). Periplasmic expression optimization of VEGFR2 D3 adopting response surface methodology: Antiangiogenic activity study. Protein Expression and Purification, 90(2), 55\u201366.","journal-title":"Protein Expression and Purification"},{"issue":"3","key":"1057_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1006\/bbrc.1998.9717","volume":"252","author":"X Huang","year":"1998","unstructured":"Huang, X., Gottstein, C., Brekken, R. A., & Thorpe, P. E. (1998). Expression of soluble VEGF receptor 2 and characterization of its binding by surface plasmon resonance. Biochemical and Biophysical Research Communications, 252(3), 643\u2013648.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"1057_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.yexmp.2003.10.010","volume":"76","author":"B Kou","year":"2004","unstructured":"Kou, B., Li, Y., Zhang, L., Zhu, G., Wang, X., Li, Y., et al. (2004). In vivo inhibition of tumor angiogenesis by a soluble VEGFR-2 fragment. Experimental and Molecular Pathology, 76(2), 129\u2013137.","journal-title":"Experimental and Molecular Pathology"},{"issue":"7","key":"1057_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.biopha.2013.06.001","volume":"67","author":"H Li","year":"2013","unstructured":"Li, H., Cao, W., Chen, Z., Acheampong, D. O., Jin, H., Li, D., et al. (2013). The antiangiogenic activity of a soluble fragment of the VEGFR extracellular domain. Biomedicine & Pharmacotherapy, 67(7), 599\u2013606.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"1057_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1006\/excr.1998.4039","volume":"241","author":"W Roeckl","year":"1998","unstructured":"Roeckl, W., Hecht, D., Sztajer, H., Waltenberger, J., Yayon, A., & Weich, H. A. (1998). Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Experimental Cell Research, 241(1), 161\u2013170.","journal-title":"Experimental Cell Research"},{"issue":"6","key":"1057_CR13","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/btpr.252","volume":"25","author":"J Zhang","year":"2009","unstructured":"Zhang, J., Li, H., Chen, W., Cao, P., & Wang, M. (2009). Preparation of extracellular domain 3 of human VEGF receptor-2 and the monitoring of its real-time binding to VEGF by biosensors. Biotechnology Progress, 25(6), 1703\u20131708.","journal-title":"Biotechnology Progress"},{"issue":"2","key":"1057_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1021\/acs.jproteome.6b00738","volume":"16","author":"KB Chandler","year":"2017","unstructured":"Chandler, K. B., Leon, D. R., Meyer, R. D., Rahimi, N., & Costello, C. E. (2017). Site-specific N-glycosylation of endothelial cell receptor tyrosine kinase VEGFR-2. Journal of Proteome Research, 16(2), 677\u2013688.","journal-title":"Journal of Proteome Research"},{"issue":"19","key":"1057_CR15","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1111\/febs.12956","volume":"281","author":"F Ghavamipour","year":"2014","unstructured":"Ghavamipour, F., Shahangian, S. S., Sajedi, R. H., Arab, S. S., Mansouri, K., & Aghamaali, M. R. (2014). Development of a highly-potent anti-angiogenic VEGF 8\u2013109 heterodimer by directed blocking of its VEGFR-2 binding site. The FEBS Journal, 281(19), 4479\u20134494.","journal-title":"The FEBS Journal"},{"key":"1057_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ijbiomac.2015.02.047","volume":"77","author":"SS Shahangian","year":"2015","unstructured":"Shahangian, S. S., Sajedi, R. H., Hasannia, S., Jalili, S., Mohammadi, M., Taghdir, M., et al. (2015). A conformation-based phage-display panning to screen neutralizing anti-VEGF VHHs with VEGFR2 mimicry behavior. International Journal of Biological Macromolecules, 77, 222\u2013234.","journal-title":"International Journal of Biological Macromolecules"},{"issue":"1","key":"1057_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/cas.15594","volume":"114","author":"Y Cao","year":"2023","unstructured":"Cao, Y., Sun, C., Huo, G., Wang, H., Wu, Y., Wang, F., et al. (2023). Novel hKDR mouse model depicts the antiangiogenesis and apoptosis-promoting effects of neutralizing antibodies targeting vascular endothelial growth factor receptor 2. Cancer Science, 114(1), 115\u2013128.","journal-title":"Cancer Science"},{"key":"1057_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pep.2016.05.001","volume":"124","author":"E Dehnavi","year":"2016","unstructured":"Dehnavi, E., Siadat, S. O. R., Roudsari, M. F., & Khajeh, K. (2016). Cloning and high-level expression of \u03b2-xylosidase from Selenomonas ruminantium in Pichia pastoris by optimizing of pH, methanol concentration and temperature conditions. Protein Expression and Purification, 124, 55\u201361.","journal-title":"Protein Expression and Purification"},{"issue":"1\u20132","key":"1057_CR19","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0022-1759(87)90187-6","volume":"100","author":"JD Beatty","year":"1987","unstructured":"Beatty, J. D., Beatty, B. G., & Vlahos, W. G. (1987). Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. Journal of Immunological Methods, 100(1\u20132), 173\u2013179.","journal-title":"Journal of Immunological Methods"},{"key":"1057_CR20","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.13876","volume":"5","author":"S Sarabipour","year":"2016","unstructured":"Sarabipour, S., Ballmer-Hofer, K., & Hristova, K. (2016). VEGFR-2 conformational switch in response to ligand binding. eLife, 5, e13876.","journal-title":"eLife"},{"key":"1057_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6150-7-30","volume":"7","author":"IS Povolotskaya","year":"2012","unstructured":"Povolotskaya, I. S., Kondrashov, F. A., Ledda, A., & Vlasov, P. K. (2012). Stop codons in bacteria are not selectively equivalent. Biology Direct, 7, 1\u201313.","journal-title":"Biology Direct"},{"key":"1057_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/jimb\/kuad018","author":"MC Gruenberg","year":"2023","unstructured":"Gruenberg, M. C., & TerAvest, M. A. (2023). A common inducer molecule enhances sugar utilization by Shewanella oneidensis MR-1. Journal of Industrial Microbiology and Biotechnology. https:\/\/doi.org\/10.1093\/jimb\/kuad018","journal-title":"Journal of Industrial Microbiology and Biotechnology"},{"key":"1057_CR23","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0032-9592(00)00137-0","volume":"35","author":"BV Kilikian","year":"2000","unstructured":"Kilikian, B. V., Su\u00e1rez, I. D., Liria, C. W., & Gombert, A. K. (2000). Process strategies to improve heterologous protein production in Escherichia coli under lactose or IPTG induction. Process Biochemistry, 35, 1019\u20131025.","journal-title":"Process Biochemistry"},{"key":"1057_CR24","first-page":"1781","volume":"119","author":"KA Lepp\u00e4nenc","year":"2011","unstructured":"Lepp\u00e4nenc, K. A., Winklerb, F. K., & Ballmer-Hofera, K. (2011). Thermodynamic and structural description of allosterically regulated VEGF receptor 2 dimerization. Blood, the Journal of the American Society of Hematology, 119, 1781\u20131788.","journal-title":"Blood, the Journal of the American Society of Hematology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01057-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01057-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01057-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T07:18:20Z","timestamp":1735888700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01057-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,13]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1057"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01057-1","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"type":"print","value":"1073-6085"},{"type":"electronic","value":"1559-0305"}],"subject":[],"published":{"date-parts":[[2024,2,13]]},"assertion":[{"value":"7 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}